EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 2
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

Wave delays key data readout for Huntington’s therapy

Studies of two experimental Huntington's disease treatments from Wave Life Sciences aren't enrolling as fast as the company expected, implying that topline data won'...
18 April 2019 Asia Pacific | news | Regional News
Continue Reading →
news

Almac Group Publishes Comparison Report on Automated vs Paper based Accountability & Reconciliation

Cost analysis findings include savings of over $1 million per trial Souderton, PA, USA,  8 April 2019 – Almac Clinical Technologies, a member of the Almac Group, h...
15 April 2019 news | North America | Regional News
Continue Reading →
Europe

Innovative Medicines Initiative launches translational safety biomarker pipeline project to enable development and implementation of novel safety biomarkers

Mönchengladbach, April 15, 2019 - The Innovative Medicines Initiative (IMI) today announced the launch of the Translational Safety Biomarker Pipeline (TransBio...
15 April 2019 Europe | news | Regional News
Continue Reading →
Asia Pacific

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in ...
8 April 2019 Asia Pacific | news | North America | Regional News
Continue Reading →
news

New clinical trials to investigate combination immunotherapy for treating advanced cancers

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearl...
8 April 2019 news | North America | Regional News
Continue Reading →
Europe

Sangamo hemophilia A progress boosts shares

An experimental gene therapy for hemophilia A helped to restore activity of an essential blood-clotting protein in several patients with the blood disorder, boost...
8 April 2019 Europe | news | North America | Regional News
Continue Reading →
Europe

United Therapeutics tosses out esuberaprost after trial flop

This comes as United Therapeutics has been doing a series of pacts and buyouts amid generic competition. (Bryan Brandenburg/CC by-SA 3.0) United Therapeutics is ...
8 April 2019 Europe | news | North America | Regional News
Continue Reading →
news

Pfizer wins expanded Ibrance approval using real world data

Pfizer on Thursday secured an expanded U.S. approval for its breast cancer drug Ibrance to men, relying not on clinical study but rather on data from electronic heal...
8 April 2019 news | North America | Regional News
Continue Reading →
Europe

No return for the Merrimack

Merrimack Pharmaceuticals is shelving yet another lead candidate after a review of Phase 1 safety data found the drug wasn't going to meet an "optimal therapeutic in...
8 April 2019 Europe | news | North America | Regional News
Continue Reading →
news

Myoderm Executive Leadership Announcement

CEO Michael Cohen to become Executive Chairman; COO James Lovett to be promoted to CEO Norristown, PA, April 2, 2019 -- Myoderm, a global clinical trial supply co...
5 April 2019 news | North America | Regional News
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte